Sarah L Barker1, Johanne Pastor2, Danielle Carranza1, Henry Quiñones3, Carolyn Griffith4, Regina Goetz5, Moosa Mohammadi5, Jianfeng Ye4, Jianning Zhang3, Ming Chang Hu6, Makoto Kuro-o7, Orson W Moe8, Sachdev S Sidhu1. 1. Banting and Best Department of Medical Research and Department of Molecular Genetics, The Donnelly Centre, University of Toronto, Toronto, ON, Canada. 2. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. 3. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. 4. Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA. 5. Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA. 6. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA. 7. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA. 8. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract
BACKGROUND: αKlotho is the prototypic member of the Klotho family and is most highly expressed in the kidney. αKlotho has pleiotropic biologic effects, and in the kidney, its actions include regulation of ion transport, cytoprotection, anti-oxidation and anti-fibrosis. In rodent models of chronic kidney disease (CKD), αKlotho deficiency has been shown to be an early biomarker as well as a pathogenic factor. The database for αKlotho in human CKD remains controversial even after years of study. METHODS: We used a synthetic antibody library to identify a high-affinity human antigen-binding fragment that recognizes human, rat and mouse αKlotho primarily in its native, rather than denatured, form. RESULTS: Using an immunoprecipitation-immunoblot (IP-IB) assay, we measured both serum and urinary levels of full-length soluble αKlotho in humans and established that human CKD is associated with αKlotho deficiency in serum and urine. αKlotho levels were detectably lower in early CKD preceding disturbances in other parameters of mineral metabolism and progressively declined with CKD stages. We also found that exogenously added αKlotho is inherently unstable in the CKD milieu suggesting that decreased production may not be the sole reason for αKlotho deficiency. CONCLUSION: Synthetic antibody libraries harbor tremendous potential for a variety of biomedical and clinical applications. Using such a reagent, we furnish data in support of αKlotho deficiency in human CKD, and we set the foundation for the development of diagnostic and therapeutic applications of anti-αKlotho antibodies.
BACKGROUND: αKlotho is the prototypic member of the Klotho family and is most highly expressed in the kidney. αKlotho has pleiotropic biologic effects, and in the kidney, its actions include regulation of ion transport, cytoprotection, anti-oxidation and anti-fibrosis. In rodent models of chronic kidney disease (CKD), αKlotho deficiency has been shown to be an early biomarker as well as a pathogenic factor. The database for αKlotho in human CKD remains controversial even after years of study. METHODS: We used a synthetic antibody library to identify a high-affinity human antigen-binding fragment that recognizes human, rat and mouse αKlotho primarily in its native, rather than denatured, form. RESULTS: Using an immunoprecipitation-immunoblot (IP-IB) assay, we measured both serum and urinary levels of full-length soluble αKlotho in humans and established that human CKD is associated with αKlotho deficiency in serum and urine. αKlotho levels were detectably lower in early CKD preceding disturbances in other parameters of mineral metabolism and progressively declined with CKD stages. We also found that exogenously added αKlotho is inherently unstable in the CKD milieu suggesting that decreased production may not be the sole reason for αKlotho deficiency. CONCLUSION: Synthetic antibody libraries harbor tremendous potential for a variety of biomedical and clinical applications. Using such a reagent, we furnish data in support of αKlotho deficiency in human CKD, and we set the foundation for the development of diagnostic and therapeutic applications of anti-αKlotho antibodies.
Authors: Candace L Crasto; Richard D Semba; Kai Sun; Anne R Cappola; Stefania Bandinelli; Luigi Ferrucci Journal: Rejuvenation Res Date: 2012-04-24 Impact factor: 4.663
Authors: Serdar Uysal; Valeria Vásquez; Valentina Tereshko; Kaori Esaki; Frederic A Fellouse; Sachdev S Sidhu; Shohei Koide; Eduardo Perozo; Anthony Kossiakoff Journal: Proc Natl Acad Sci U S A Date: 2009-04-03 Impact factor: 11.205
Authors: Y Matsumura; H Aizawa; T Shiraki-Iida; R Nagai; M Kuro-o; Y Nabeshima Journal: Biochem Biophys Res Commun Date: 1998-01-26 Impact factor: 3.575
Authors: Hiroshi Kurosu; Masaya Yamamoto; Jeremy D Clark; Johanne V Pastor; Animesh Nandi; Prem Gurnani; Owen P McGuinness; Hirotaka Chikuda; Masayuki Yamaguchi; Hiroshi Kawaguchi; Iichiro Shimomura; Yoshiharu Takayama; Joachim Herz; C Ronald Kahn; Kevin P Rosenblatt; Makoto Kuro-o Journal: Science Date: 2005-08-25 Impact factor: 47.728
Authors: Y Ohyama; M Kurabayashi; H Masuda; T Nakamura; Y Aihara; T Kaname; T Suga; M Arai; H Aizawa; Y Matsumura; M Kuro-o; Y i Nabeshima; R Nagail Journal: Biochem Biophys Res Commun Date: 1998-10-29 Impact factor: 3.575
Authors: Anders Nordholm; Maria L Mace; Eva Gravesen; Jacob Hofman-Bang; Marya Morevati; Klaus Olgaard; Ewa Lewin Journal: Am J Physiol Renal Physiol Date: 2017-11-29
Authors: Ming Chang Hu; Mingjun Shi; Jianning Zhang; Tayo Addo; Han Ju Cho; Sarah L Barker; Priya Ravikumar; Nancy Gillings; Ao Bian; Sachdev S Sidhu; Makoto Kuro-o; Orson W Moe Journal: J Am Soc Nephrol Date: 2015-05-14 Impact factor: 10.121